WTA
NARI

Washington Trust Advisors’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Washington Trust Advisors’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-46
Closed -$2.35K – 674
2024
Q4 		$2.35K Hold
46
– – ﹤0.01% 614
2024
Q3 		$1.9K Hold
46
– – ﹤0.01% 637
2024
Q2 		$2.21K Hold
46
– – ﹤0.01% 629
2024
Q1 		$2.21K Hold
46
– – ﹤0.01% 636
2023
Q4 		$2.99K Hold
46
– – ﹤0.01% 628
2023
Q3 		$3.01K Hold
46
– – ﹤0.01% 610
2023
Q2 		$2.67K Hold
46
– – ﹤0.01% 614
2023
Q1 		$2.84K Hold
46
– – ﹤0.01% 699
2022
Q4 		$2.92K Hold
46
– – ﹤0.01% 689
2022
Q3 		$3K Hold
46
– – ﹤0.01% 832
2022
Q2 		$3K Hold
46
– – ﹤0.01% 852
2022
Q1 		$4K Hold
46
– – ﹤0.01% 875
2021
Q4 		$4K Buy
+46
New +$3.94K ﹤0.01% 903

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

Washington Trust Advisors's NARI Position: Q1 2025 in Review

Washington Trust Advisors sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 46 shares — an estimated $2.35K sold.

Washington Trust Advisors first reported a position in NARI in Q4 2021 and held it in 13 quarters. The position peaked at $4K in Q1 2022. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Washington Trust Advisors reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Washington Trust Advisors sold 46 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $2.35K.
  • Washington Trust Advisors first reported a position in Inari Medical, Inc. Common Stock in Q4 2021 and held it in 13 quarters.
  • Washington Trust Advisors's Inari Medical, Inc. Common Stock position peaked at $4K in Q1 2022.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Washington Trust Advisors's 13F filing for Q1 2025, filed 25 Apr 2025.